Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Myeloid cells - targets of medication in multiple sclerosis.
Pediatric multiple sclerosis: The 2015 Sydney Carter Award Lecture.
Erratum to: Bone density in proton pump inhibitors users: a prospective study.
Plasma exchange therapy for a severe relapse of Devic's disease in a pregnant woman: A case report and concise review.
Fibrosis of the Choroid Plexus Filtration Membrane.
Mapping Variation in Cellular and Transcriptional Response to 1,25-Dihydroxyvitamin D3 in Peripheral Blood Mononuclear Cells.
Discovery of a new structural class of competitive hDHODH inhibitors with in vitro and in vivo anti-inflammatory, immunosuppressive effects.
Age-Related Changes in Axonal and Mitochondrial Ultrastructure and Function in White Matter.
Physical activity and the incidence of multiple sclerosis.
Response to "Vitamin D status is negatively correlated with retinal nerve fiber layer thickness in relapsing-remitting MS patients without acute optic neuritis" by Knippenberg et al.
Retraction: A. Amedei et al. Multiple Sclerosis: The Role of Cytokines in Pathogenesis and in Therapies. Int. J. Mol. Sci. 2012, 13, 13438-13460.
The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis.
Inflammation Induces TDP-43 Mislocalization and Aggregation.
Epigallocatechin-3-gallate induces oxidative phosphorylation by activating cytochrome c oxidase in human cultured neurons and astrocytes.
TLR Tolerance as a Treatment for Central Nervous System Autoimmunity.
Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis.
Regenerative Capacity of Macrophages for Remyelination.
Acute Multiple Sclerosis Relapse.
Long-Term Adherence to IFN Beta-1a Treatment when Using RebiSmart® Device in Patients with Relapsing-Remitting Multiple Sclerosis.
Teaching Video NeuroImages: Primary writing tremor: Lessons from a patient with multiple sclerosis.
Rabies virus-mediated oligodendrocyte labeling reveals a single oligodendrocyte myelinates axons from distinct brain regions.
Intravenously infused F3.Olig2 improve memory deficit via restoring demyelination in the aged hippocampus following experimental ischemic stroke.
Kynurenic Acid Induces Impairment of Oligodendrocyte Viability: On the Role of Glutamatergic Mechanisms.
Intensive social cognitive treatment (can do treatment) with participation of support partners in persons with relapsing remitting multiple sclerosis: observation of improved self-efficacy, quality of life, anxiety and depression 1 year later.
Neural Stem Cell Transplantation and CNS Diseases.
Pages
« first
‹ previous
…
771
772
773
774
775
776
777
778
779
…
next ›
last »